The long-running battle between Boston Scientific Corp. (NYSE:BSX) and Johnson & Johnson’s (NYSE:JNJ) Cordis Corp. over coronary stent patents went another round this week when a federal judge ruled that Cordis infringes a BSX patent.
Judge Susan Robinson of the U.S. District Court for Delaware granted the Natick, Mass.-based catheter pioneer’s move for summary judgment of infringement and denied a Cordis motion to delay the jury trial phase of the case, slated to begin May 5.